Cholecystokinin receptors in human pancreatic cancer cell lines

被引:16
作者
Mandair, KK
Towner, P
Stamford, IF
Morris, JD
Harper, E
Benjamin, IS
Tavares, IA
机构
[1] Univ London Kings Coll, Sch Med & Dent, Rayne Inst, Acad Dept Surg, London SE5 9NU, England
[2] Univ London Kings Coll, Sch Med & Dent, Rayne Inst, Dept Mol Med, London SE5 9NU, England
[3] James Black Fdn, London, England
关键词
human pancreatic cancer; cell lines; cholecystokinin receptors; focal adhesion kinase; K-ras;
D O I
10.1016/S0959-8049(98)00143-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have suggested that cholecystokinin (CCK) receptors may play a role in the development and growth of pancreatic cancers. We detected the expression of mRNA encoding CCK-A and CCK-B receptors in eight human pancreatic tumour cell lines using reverse transcription-polymerase chain reaction (RT-PCR), but not by RNase protection assays. The K-ras gene, which can be activated by G-coupled protein receptors such as CCK receptors, was mutated in codon 12 in five of the cell lines. In addition, Mia PaCa-2 pancreatic cancer cells did not respond to CCK or gastrin in cell proliferation or focal adhesion kinase (FAK) phosphorylation assays. In contrast, mouse NIH3T3 fibroblasts transfected with human CCK-B receptor (NIH3T3CCK-BR) showed increased proliferation and phosphorylation to the peptides. Also, radioligand binding studies indicated that Mia PaCa-2 cells had approximately 12.5-fold less CCK-B receptors than NIH3T3CCK-BR. Our results suggest that in Mia PaCa-2 cells, CCK receptors may not play a crucial role in supporting cell growth. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1455 / 1459
页数:5
相关论文
共 28 条
  • [1] MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES
    ALMOGUERA, C
    SHIBATA, D
    FORRESTER, K
    MARTIN, J
    ARNHEIM, N
    PERUCHO, M
    [J]. CELL, 1988, 53 (04) : 549 - 554
  • [2] ABNORMALITIES OF THE P53 TUMOR SUPPRESSOR GENE IN HUMAN PANCREATIC-CANCER
    BARTON, CM
    STADDON, SL
    HUGHES, CM
    HALL, PA
    OSULLIVAN, C
    KLOPPEL, G
    THEIS, B
    RUSSELL, RCG
    NEOPTOLEMOS, J
    WILLIAMSON, RCN
    LANE, DP
    LEMOINE, NR
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (06) : 1076 - 1082
  • [3] BORING CC, 1993, CA-CANCER J CLIN, V43, P18
  • [4] FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA
    CALDAS, C
    HAHN, SA
    DACOSTA, LT
    REDSTON, MS
    SCHUTTE, M
    SEYMOUR, AB
    WEINSTEIN, CL
    HRUBAN, RH
    YEO, CJ
    KERN, SE
    [J]. NATURE GENETICS, 1994, 8 (01) : 27 - 32
  • [5] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [6] STIMULATION OF PANCREATIC GROWTH BY SECRETIN, CERULEIN, AND PENTAGASTRIN
    DEMBINSKI, AB
    JOHNSON, LR
    [J]. ENDOCRINOLOGY, 1980, 106 (01) : 323 - 328
  • [7] MOLECULAR-CLONING, FUNCTIONAL EXPRESSION AND CHROMOSOMAL LOCALIZATION OF THE HUMAN CHOLECYSTOKININ TYPE-A RECEPTOR
    DEWEERTH, A
    PISEGNA, JR
    HUPPI, K
    WANK, SA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) : 811 - 818
  • [8] FUNAKOSHI A, 1992, GASTROENTEROL JPN, V27, P78
  • [9] DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
    Hahn, SA
    Schutte, M
    Hoque, ATMS
    Moskaluk, CA
    daCosta, LT
    Rozenblum, E
    Weinstein, CL
    Fischer, A
    Yeo, CJ
    Hruban, RH
    Kern, SE
    [J]. SCIENCE, 1996, 271 (5247) : 350 - 353
  • [10] DEMONSTRATION OF A PUTATIVE RECEPTOR-SITE FOR CHOLECYSTOKININ IN RAT-BRAIN
    HAYS, SE
    BEINFELD, MC
    JENSEN, RT
    GOODWIN, FK
    PAUL, SM
    [J]. NEUROPEPTIDES, 1980, 1 (01) : 53 - 62